WMDH yields 2000000.00% · JNJ yields 2.13%● Live data
📍 WMDH pulled ahead of the other in Year 1
Combined, WMDH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WMDH + JNJ for your $10,000?
WMD Holdings Group, Inc. engages in the development and deployment of turnkey solutions for financial and payment processing, prepaid services, telecommunications, and interactive broadcasting networks in the United States. The company offers NAVITOUCH, an interactive broadcast network system that enables worldwide broadcasting of interactive content and advertising to various touch screen monitors; local and long-distance telephone services; and financial, payment, and communication services through its point of sale terminals, which facilitate the recharge and distribution of a multitude of pre-paid offerings, including pre-paid debit cards, pre-paid wireless distribution, and pre-paid long distance. It also provides debit card solutions; closed loop stored value and gift card programs; check cashing and bill payment services; cell phone sales; shipping; and money transfers. In addition, WMD Holdings offers payday advances and loans to consumers requiring emergency funding, short term bridge loans, and advances on payroll. It primarily distributes its solutions through a combination of company owned and operated locations, online, and other independent sales organizations to the financial, payment processing, telecommunications, and advertising industries. The company was founded in 2001 and is based in Huntington Beach, California.
Full WMDH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.